1. To understand the complicated history of controlled human infection, or challenge, studies.
2. To be able to identify salient ethical considerations for controlled human infection studies.
3. To be able to articulate potential ethically acceptable conditions and uses for controlled human infection studies to address COVID-19.
02/24/2021 - 12:00pm to 1:30pm CST
Add to calendar:
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Participation
Seema Shah, JD